共 198 条
[1]
Fleischmajer R(1977)Cellular infiltrates in scleroderma skin Arthritis Rheum 20 975-984
[2]
Perlish JS(2006)Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients Rheumatology (Oxford) 45 694-702
[3]
Reeves JR(1997)Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis Am J Pathol 151 1751-1758
[4]
Tan FK(1992)Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma Arthritis Rheum 35 67-72
[5]
Zhou X(1999)Increased interferon-gamma (IFN-gamma) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon Clin Exp Immunol 116 164-168
[6]
Mayes MD(1998)Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis J Rheumatol 25 308-313
[7]
Gourh P(1999)Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis Rheumatology (Oxford) 38 612-617
[8]
Guo X(2001)Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis J Dermatol Sci 27 140-146
[9]
Marcum C(1997)Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis J Rheumatol 24 663-665
[10]
Jin L(1997)Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis J Rheumatol 24 328-332